63 related articles for article (PubMed ID: 7512598)
1. Definition of a DQ3.1-specific binding motif.
Sidney J; Oseroff C; del Guercio MF; Southwood S; Krieger JI; Ishioka GY; Sakaguchi K; Appella E; Sette A
J Immunol; 1994 May; 152(9):4516-25. PubMed ID: 7512598
[TBL] [Abstract][Full Text] [Related]
2. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus.
Ettinger RA; Kwok WW
J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Kwok WW; Nepom GT; Raymond FC
J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
5. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
6. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
[TBL] [Abstract][Full Text] [Related]
7. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
[TBL] [Abstract][Full Text] [Related]
8. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries.
Volz T; Schwarz G; Fleckenstein B; Schepp CP; Haug M; Roth J; Wiesmüller KH; Dannecker GE
Hum Immunol; 2004 Jun; 65(6):594-601. PubMed ID: 15219379
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQB1 codon 57 is critical for peptide binding and recognition.
Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM
J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268
[TBL] [Abstract][Full Text] [Related]
11. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
[TBL] [Abstract][Full Text] [Related]
12. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice.
Krco CJ; Watanabe S; Harders J; Griffths MM; Luthra H; David CS
J Immunol; 1999 Aug; 163(3):1661-5. PubMed ID: 10415072
[TBL] [Abstract][Full Text] [Related]
13. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
14. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein.
Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T
J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773
[TBL] [Abstract][Full Text] [Related]
15. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201.
Koelle DM; Johnson ML; Ekstrom AN; Byers P; Kwok WW
Hum Immunol; 1997 Apr; 53(2):195-205. PubMed ID: 9129979
[TBL] [Abstract][Full Text] [Related]
16. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles.
Sidney J; Oseroff C; Southwood S; Wall M; Ishioka G; Koning F; Sette A
J Immunol; 1992 Oct; 149(8):2634-40. PubMed ID: 1401902
[TBL] [Abstract][Full Text] [Related]
17. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
Sidney J; del Guercio MF; Southwood S; Sette A
J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
[TBL] [Abstract][Full Text] [Related]
18. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
20. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
